Acute tamoxifen treatment increases nitric oxide level but not total antioxidant capacity and adenosine deaminase activity in the plasma of rabbits

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 4, 2009, Pages 239-243

  Atakisi, Emine ^a   Kart, A ^a   Atakisi, O ^a   Topcu, B ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Nitric oxide; Tamoxifen; Total antioxidant capacity

Indexed keywords

ADENOSINE DEAMINASE; NITRIC OXIDE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; NONHUMAN; RABBIT; SHORT COURSE THERAPY;

ADENOSINE DEAMINASE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIOXIDANTS; IMMUNITY, CELLULAR; NITRIC OXIDE; RABBITS; TAMOXIFEN; TIME FACTORS;

EID: 69249101321     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. JORDAN VC. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 1993; 110: 507-517.
2. HASKELL SG. Selective estrogen receptor modulators. South Med J 2003; 96: 469-476.
3. CLARKE MJ. WITHDRAWN: Tamoxifen for early breast cancer. Cochrane Database Syst Rev 2008; (4): CD000486.
4. WICKERHAM DL, COSTANTINO JP, VOGEL VG, CRONIN WM, CECCHINI RS, FORD LG, WOLMARK N. The use of tamoxifen and raloxifene for the prevention of breast cancer. Recent Results Cancer Res 2009; 181: 113-119.
5. OBATA T. Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum. Toxicology 2006; 222: 46-52.
6. CUSTODIO JB, DINIS TC, ALMEIDA LM, MADEIRA VM. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem Pharmacol 1994; 47: 1989-1998.
7. MOREIRA PI, CUSTODIO JB, OLIVEIRA CR, SANTOS MS. Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen. Neuropharmacology 2005; 48: 435-447.
8. THANGARAJU M, VLJAYALAKSHMI T, SACHDANANDAM P. Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer 1994; 74: 78-82.
9. 2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett 1999; 147: 115-123.
10. O'BRIAN CA, LISKAMP RM, SOLOMON DH, WEINSTEIN IB. Inhibition of protein kinase C by tamoxifen. Cancer Res 1985; 45: 2462-2465.
11. OSUKA K, FEUSTEL PJ, MONGIN AA, TRANMER BI, KIMELBERG HK. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J Neurochem 2001; 76: 1842-1850.
12. LOO SA, LESOON-WOOD LA, COONEY RV. Effects of tamoxifen on nitric oxide synthesis and neoplastic transformation in C3H 10T1/2 fibroblasts. Cancer Lett 1998; 122: 67-75.
13. LIM JS, FRENKEL K, TROLL W. Tamoxifen suppresses tumor promoter-induced hydrogen peroxide formation by human neutrophils. Cancer Res 1992; 52: 4969-4972.
14. SULLIVAN JL, OSBORNE WR, WEDGEWOOD RJ. Adenosine deaminase activity in lymphocytes. Br J Haematol 1977; 37: 157-158.
15. KAUL A, CHANDRA M, MISRA MK. Erythrocyte adenosine deaminase as a marker of reperfusion injury in patients with myocardial infarction. Int J Cardiol 2007; 115: 274-275.
16. KAUL A, MISRA MK, SETHI R. Evaluation of the roles of adenosine deaminase and xanthine oxidase in reperfusion injury in patients with myocardial infarction. Clin Chim Acta 2007; 380: 225-227.
17. SOMOGYI A, ROSTA K, PUSZTAI P, TULASSAY Z, NAGY G. Antioxidant measurements. Physiol Meas 2007; 28: R41-55.
18. MIRANDA KM, ESPEY MG, WINK DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71.
19. EREL O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
20. GIUSTI B, GALANTI B. Methods of enzymatic analysis. In: Bergmeyer HU, eds. Adenosine deaminase: colorimetric method, Weinheim: Verlac Chemie; 1984.
21. WISEMAN H, LAUGHTON MJ, ARNSTEIN HR, CANNON M, HALLIWELL B. The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation. FEBS Lett 1990; 263: 192-194.
22. OBATA T, KUBOTA S. Protective effect of tamoxifen on 1-methyl-4- phenylpyridine-induced hydroxyl radical generation in the rat striatum. Neurosci Lett 2001; 308: 87-90.
23. TABASSUM H, REHMAN H, BANERJEE BD, RAISUDDIN S, PARVEZ S. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim Acta 2006; 370: 129-136.
24. TRIPATHI K, KUMAR R, BHARTI K, KUMAR P, SHRIVASTAV R, SUNDAR S, PAI K. Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India. Clin Chim Acta 2008; 388: 135-138.
25. ERKILIC K, EVEREKLIOGLU C, CEKMEN M, OZKIRIS A, DUYGULU F, DOGAN H. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behcet's disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 2003; 12: 107-116.
26. HOFSETH LJ, HUSSAIN SP, WOGAN GN, HARRIS CC. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 2003; 34: 955-968.
27. HOFSETH LJ. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Lett 2008; 268: 10-30.
28. COSKUN U, GUNEL N, SANCAK B, ONUK E, BAYRAM M, CIHAN A. Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. Clin Exp Immunol 2004; 137: 546-551.